What exactly changed in the GRRMF analyst rating on Feb 23, 2026?

On **February 23, 2026** UBS downgraded Gerresheimer AG from **Neutral** to **Sell**. That is the only rating change recorded for GRRMF in this update, and UBS did not publish a price target alongside the downgrade.

How should investors interpret a Sell under the GRRMF analyst rating?

A Sell suggests UBS expects GRRMF to underperform peers or the market. Investors should reassess position size, review downside scenarios, and consider liquidity needs before holding or adding to the stock.

Did UBS provide a GRRMF price target with the downgrade?

No. The UBS note cited by TheFly did not include a price target for GRRMF, leaving valuation guidance absent and making follow-up research more important for price context.

Where can I follow updates to the GRRMF analyst rating?

Monitor live analyst coverage pages and company releases. Meyka AI tracks real-time changes and lists sources like TheFly for notes such as UBS’s **Feb 23, 2026** downgrade of GRRMF.

Analyst Ratings

UBS Downgrades Gerresheimer AG (GRRMF) to Sell on Feb 23, 2026

ByHuzaifa Zahoor February 24, 2026February 24, 2026

UBS downgraded Gerresheimer AG to Sell from Neutral on February 23, 2026, marking a clear change in the GRRMF analyst rating landscape. This single action from UBS is the only rating change today and comes with no price target disclosed. Investors should note Gerresheimer’s market cap of $1,775,701,400 and that the company now sits under increased downside risk in analyst sentiment.